Tracheal rhinoscleroma treated by argon laser.

Williams, I P; Radcliffe, G.; Hetzel, M; Millard, Jonathan A.

doi:10.1136/thx.37.8.638

Cited by 6 publications

(2 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The management of scleromatous cicatricial lesions of the lower respiratory tract may involve periodic endoscopic dilatations (Tapia-Acufia, 1973), laser excision (Williams et al, 1982) or surgical resection and reconstruction of the involved segments of larynx and trachea (Tahae/ al., 198r;Rifai, 1989). The long-term use of intraluminal stents has been considered necessary when reconstructive surgery is used in the treatment of scleromatous laryngotracheal stenosis (Tapia-Acuna, 1973;Holinger et al, 1977;Taha et al, 1981) because residual or recurrent activity of the disease may be a setback for an initially successful surgery (Rifai, 1989).…”

Section: Discussionmentioning

confidence: 99%

Scleroma of the lower respiratory tract: case report and review of literature

1994

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Scleroma of the lower respiratory tract: case report and review of literature

1994

View full text Add to dashboard Cite

show abstract

“…Lasers can also be helpful in rare, refractory inflammatory lesions such as rhinoscleroma [22] or amyloidosis when obstruction or hemoptysis are the main symptoms. Lasers have also been used in more questionable applications, although the advantages over conventional surgical techniques are far from proven.…”

Section: Laser Treatment Of Nonmalignant Tracheobronehial Lesionsmentioning

confidence: 99%

Current use of lasers in pulmonary disease

Hetzel

1983

World j. surg.

View full text Add to dashboard Cite

The principal role of lasers in pulmonary medicine is, and will probably remain, in the treatment of unresectable tumors. In its most limited capacity, current research has already demonstrated them to be valuable palliation tools in carefully selected cases, where it can improve the last few months of life of patients for whom conventional treatments are ineffective. At best, high power lasers and dye laser HpD systems may eventually offer cures to some patients unsuitable for surgery because of poor respiratory reserve, when the total tumor mass is endoscopically accessible. It is clear, however, that only a minority of lung cancer patients are suitable for laser therapy, and lasers should only be regarded as a promising addition to the current armamentarium against this depressingly lethal disease; rather than a replacement for currently accepted treatments.

show abstract

Laser Bronchoscopy: An American Experience

Casey¹

1990

Medical Laser Endoscopy

View full text Add to dashboard Cite

Tracheal rhinoscleroma treated by argon laser.

Cited by 6 publications

References 1 publication

Scleroma of the lower respiratory tract: case report and review of literature

Scleroma of the lower respiratory tract: case report and review of literature

Current use of lasers in pulmonary disease

Laser Bronchoscopy: An American Experience

Contact Info

Product

Resources

About